GHK-Cu vs TB-500: Comparing Two Tissue-Repair Research Peptides

For Research Use Only. Not for human or veterinary use. All information below is intended for qualified research professionals at accredited institutions.

TL;DR

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex, CAS 49557-75-7) is a copper-chelating tripeptide studied in dermatological, wound healing, and gene regulation research.
TB-500 (Thymosin Beta-4 fragment, CAS 77591-33-4) is a synthetic actin-sequestering peptide fragment studied in tissue repair, cell migration, and angiogenesis models.
Both are classified as tissue-repair research tool compounds but operate through mechanistically distinct pathways: GHK-Cu via copper-mediated signaling and gene regulatory effects; TB-500 via actin-sequestering and cytoskeletal remodeling mechanisms.

The tissue repair research space contains a diverse set of peptide tool compounds that have been studied in models of wound healing, dermal biology, and connective tissue remodeling. GHK-Cu and TB-500 are two of the most well-characterized in this category, each with an extensive published research record documenting distinct mechanisms. Despite both being broadly classified as “tissue repair peptides” in research contexts, their molecular targets, signaling pathways, and experimental applications are substantially different. This overview provides research professionals with a mechanistic framework for distinguishing and selecting between these compounds.

Mechanism: GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex)

GHK-Cu is the copper(II) chelate of the tripeptide glycyl-L-histidyl-L-lysine (GHK). The GHK tripeptide was originally isolated from human plasma albumin and subsequently characterized as an endogenous copper-binding sequence with high affinity for Cu²⁺ ions, particularly at the imidazole nitrogen of the histidine residue. The copper complex is the biologically active form studied in most published research.

Copper coordination chemistry: The GHK tripeptide coordinates copper(II) through a square planar or distorted square planar coordination geometry involving the terminal amine nitrogen, the amide nitrogen of Gly-His, the imidazole nitrogen of histidine, and a water molecule or the lysine amino group depending on pH. This tight copper binding gives GHK-Cu a copper carrier function that has been studied in the context of copper delivery to copper-dependent enzymes such as lysyl oxidase (LOX), which crosslinks collagen and elastin, and Cu/Zn superoxide dismutase (SOD1).

Fibroblast and collagen research: Published studies using fibroblast cell culture models have documented GHK-Cu effects on collagen synthesis, with proposed mechanisms involving TGF-β pathway modulation, lysyl oxidase activity enhancement (via copper delivery), and matrix metalloproteinase (MMP) regulation. Research has characterized both stimulation of collagen type I and III synthesis and modulation of MMP-1, MMP-2, and MMP-9 expression in fibroblast models, suggesting a role in extracellular matrix remodeling regulation.

Gene regulatory research: A particularly studied dimension of GHK-Cu research involves bioinformatic analyses of its apparent effects on large gene expression datasets. Published papers have reported GHK-Cu’s modulation of several hundred genes in cell culture studies, with enrichment in gene ontology categories related to wound response, inflammation resolution, DNA repair, and antioxidant defense. The mechanism by which a tripeptide-copper complex influences such a broad gene set is not fully elucidated and remains an active area of research investigation.

Key specifications:

CAS: 49557-75-7
Molecular formula: C₁₄H₂₂CuN₆O₄
MW: 403.90 Da
Purity: ≥99% HPLC
Available: 100mg × 10 vials
Storage: -20°C, desiccated, light-protected
Product page: glunovabiotech.com/products/ghk-cu

Mechanism: TB-500 (Thymosin Beta-4 Fragment)

TB-500 is a synthetic peptide corresponding to a fragment of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein that is one of the most abundant intracellular proteins in eukaryotic cells, found at particularly high concentrations in platelets and white blood cells. Tβ4’s primary biochemical function is as the principal G-actin sequestering protein in mammalian cells.

Actin sequestration mechanism: The actin cytoskeleton in eukaryotic cells exists in dynamic equilibrium between monomeric G-actin and polymerized F-actin filaments. This equilibrium is tightly regulated by a network of actin-binding proteins. Thymosin Beta-4 binds G-actin monomers via its LKKTET actin-binding motif (residues 17–23 of full-length Tβ4), sequestering them in a non-polymerizable complex and maintaining a pool of monomeric actin available for rapid filament nucleation when cytoskeletal remodeling signals are received. TB-500, as a synthetic fragment containing the relevant binding region, retains this actin-regulatory activity in research assays.

Cell migration and wound healing models: The connection between actin pool regulation and cell migration provides the mechanistic basis for TB-500’s study in wound healing models. Cell migration requires rapid, localized actin polymerization at the leading edge (lamellipodia formation), and the availability of G-actin monomers — regulated by Tβ4/TB-500 — is a rate-limiting factor in this process. Published preclinical research has used Tβ4 and related fragments in corneal wound healing models, cardiac tissue regeneration studies, and in vitro scratch assay wound closure experiments with endothelial and epithelial cell lines.

Angiogenesis and endothelial biology: Beyond actin-mediated cell migration, research has examined Tβ4 and TB-500 fragments in endothelial cell models, documenting effects on tube formation assays (a standard in vitro angiogenesis model), endothelial cell migration, and in some studies, modulation of inflammatory mediator production. Proposed mechanisms include interactions with integrin signaling and vascular endothelial growth factor (VEGF) pathway crosstalk.

Key specifications:

CAS: 77591-33-4
Molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S
MW: 4,963.4 Da
Purity: ≥99% HPLC
Available: 10mg × 10 vials
Storage: -20°C, desiccated
Product page: glunovabiotech.com/products/tb-500

Comparison Table

Parameter	GHK-Cu	TB-500
CAS Number	49557-75-7	77591-33-4
Molecular weight	403.90 Da	4,963.4 Da
Sequence	Gly-His-Lys (tripeptide + Cu²⁺)	Thymosin Beta-4 fragment (~24 AA)
Primary target	Copper coordination; ECM enzymes; gene regulatory networks	G-actin monomers (LKKTET motif binding)
Primary mechanism	Copper delivery, MMP modulation, collagen/ECM synthesis	Actin sequestration, cytoskeletal remodeling, cell migration
Key research context	Dermatology, skin biology, ECM remodeling, gene regulation	Wound healing, angiogenesis, cardiac/corneal repair models
Available packaging	100mg × 10 vials	10mg × 10 vials
Purity	≥99% HPLC	≥99% HPLC
Storage	-20°C, light-protected	-20°C, desiccated

Research Applications

GHK-Cu research applications:

Fibroblast proliferation and collagen synthesis assays (hydroxyproline quantitation, qPCR for COL1A1/COL3A1)
MMP expression and activity studies (MMP-1, MMP-2, MMP-9 zymography or ELISA)
Lysyl oxidase activity assays in ECM crosslinking research
Keratinocyte migration and skin barrier reconstitution models
Antioxidant and superoxide dismutase-related activity studies (Cu/Zn SOD chemistry in model systems)
Transcriptomics studies (RNA-seq, microarray) examining GHK-Cu gene regulatory effects in skin cell lines

TB-500 research applications:

In vitro scratch/wound closure assays with endothelial (HUVEC), epithelial, or cardiac cell lines
G-actin sequestration and actin polymerization kinetics studies (pyrene-actin fluorescence assays)
Tube formation angiogenesis assays on Matrigel with endothelial cells
Corneal epithelial wound healing models
Cardiac myocyte or cardiomyocyte-derived cell line studies of cytoskeletal dynamics
Inflammatory cytokine modulation studies in macrophage models

Selecting Between GHK-Cu and TB-500

The mechanistic distinction between these two compounds should guide selection:

Select GHK-Cu for research into copper-mediated ECM biology, collagen and elastin synthesis pathways, MMP regulation, skin fibroblast pharmacology, or broad gene expression modulation studies in dermatological cell models. The higher per-vial specification (100mg) also makes GHK-Cu practical for large-scale cell culture experiments.
Select TB-500 for research focused on actin cytoskeletal dynamics, cell migration mechanisms, angiogenesis models, or wound closure assays where the Thymosin Beta-4 actin-regulatory axis is the experimental subject.
Use both in combination studies — for example in the KLOW or GLOW research blends available from Glunova Biotech — when multi-pathway tissue biology research requires simultaneous engagement of copper-mediated ECM signaling and actin-mediated cell migration mechanisms.

Ordering Information

Both GHK-Cu and TB-500 are available from Glunova Biotech LLC at ≥99% HPLC purity with COA per lot. They are also components of the KLOW (GHK-Cu + TB-500 + BPC-157 + KPV) and GLOW (GHK-Cu + BPC-157 + TB-500) research blends:

For bulk orders, institutional pricing, COA, SDS, or supply agreements: dylan.tom2012@gmail.com | +1 (586) 248-1681.

For Research Use Only. Not for human or veterinary use. These products have not been evaluated by the FDA or any regulatory agency for safety or efficacy in humans or animals.